REVIEW OF STATES' PRACTICES ON THE USE OF PSYCHOTROPIC MEDICATION
Сохранить в:
RINCK, C., ET AL., REVIEW OF STATES' PRACTICES ON THE USE OF PSYCHOTROPIC MEDICATION. AMERICAN JOURNAL ON MENTAL RETARDATION, Vol. 93, no. 6 (1989), p. 657-668.
Ref.
15503
Хранение:
SIIS R.100 Depósito (3)
Palabras clave:
Conducta, Discapacidad, Discapacidad intelectual, Fármacos, Personalidad, EE.UU.
Conducta, Discapacidad, Discapacidad intelectual, Fármacos, Personalidad, EE.UU.
Схожие документы: REVIEW OF STATES' PRACTICES ON THE USE OF PSYCHOTROPIC MEDICATION
- PSYCHOTROPIC DRUG USE IN OLDER DEVELOPMENTALLY DISABLED WITH BEHAVIORAL DIFFICULTIES
- PATTERNS OF PSYCHOTROPIC MEDICATION USE AMONG OLDERPERSONS WITH DEVELOPMENTAL DISABILITIES
- GUIDELINES FOR THE USE OF PSYCHOTROPIC MEDICATION IN INDIVIDUALS WITH DEVELOPMENTAL DISABILITIES
- PROBLEM BEHAVIOR AND PSYCHIATRIC IMPAIRMENT WITHIN A DEVELOPMENTALLY DISABLED POPULATION III: PSYCHOTROPIC MEDICATION
- THE USE OF PSYCHOTROPIC MEDICATION FOR PEOPLE WITH SEVERE DISABILITIES AND CHALLENGING BEHAVIOR: CURRENT STATUS AND FUTURE DIRECTIONS
- Factors influencing the use of psychotropic medication for challenging behaviour in the United Kingdom: a Q method investigation